Reproducibility of Intratumor Distribution of 18F-Fluoromisonidazole in Head and Neck Cancer

This publication has 36 references indexed in Scilit:

• Endogenous Markers of Two Separate Hypoxia Response Pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) Are Associated With Radiotherapy Failure in Head and Neck Cancer Patients Recruited in the CHART Randomized Trial
  Journal of Clinical Oncology, 2006
• Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study
  Radiotherapy and Oncology, 2005
• The impact of daily setup variations on head-and-neck intensity-modulated radiation therapy
  International Journal of Radiation Oncology*Biology*Physics, 2005
• Hypoxia and Glucose Metabolism in Malignant Tumors
  Clinical Cancer Research, 2004
• Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers
  Radiotherapy and Oncology, 2003
• Tumor Hypoxia Has Independent Predictor Impact Only in Patients With Node-Negative Cervix Cancer
  Journal of Clinical Oncology, 2002
• Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: A pretherapy study of 37 patients
  International Journal of Radiation Oncology*Biology*Physics, 1996
• Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers
  Seminars in Radiation Oncology, 1996
• Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography
  International Journal of Radiation Oncology*Biology*Physics, 1995
• The labelling of EMT-6 tumours in BALB/C mice with¹⁴C-misonidazole
  The British Journal of Radiology, 1983